Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: 2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients [Phase 2]
A Phase 2 clinical trial (sponsored by European LeukemiaNet) is evaluating stopping nilotinib after two years in chronic myeloid leukemia pa…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia [Phase 1, Phase 2]
An ongoing Phase 1/2 pediatric trial evaluating bosutinib for Philadelphia chromosome-positive chronic myeloid leukemia in children, includi…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients [Phase 1]
Phase 1 trial evaluating Itacitinib with high-dose posttransplantation cyclophosphamide in older patients. The study is currently ACTIVE_NOT…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the dose and safety of Asciminib in pediatric patients with Philadelphia chromosome-positive chroni…
-
EMA approval · 2025-09-11EMA Authorised: Nilotinib Accord (nilotinib) — Accord Healthcare S.L.U.
Accord Healthcare S.L.U. has been authorised to market Nilotinib Accord for chronic myeloid leukemia that is BCR-ABL positive.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network
An ongoing clinical trial in Lombardy evaluating quality of life and the organization of care for patients with chronic myeloid leukemia; th…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Cord Blood Transplant in Adults With Blood Cancers [Phase 2]
Phase 2 trial evaluating cord blood transplant in adults with blood cancers is currently recruiting. Conditions include acute myeloid leukem…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Identification of BCR::ABL1 Mutations by Digital PCR in CML [NA]
A clinical trial update describes using digital PCR to identify BCR-ABL1 mutations in chronic myeloid leukemia. The study is currently not r…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy [Phase 2]
Phase 2 clinical trial evaluating the combination of imatinib and artesunate for chronic myeloid leukemia. The study is currently active but…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: TGRX-678 Pharmacokinetic Mass Balance [Phase 1]
Phase 1 pharmacokinetic mass balance study of TGRX-678 has been completed, summarizing absorption, distribution, metabolism, and excretion c…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients
A real-world study evaluating how adverse events influence treatment changes, healthcare resource use, and costs in chronic myeloid leukemia…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan
A completed real-world study assessing treatment patterns and burden among chronic myeloid leukemia patients in Japan, sponsored by Novartis…
-
FDA approval · 2025-08-28FDA Approved: DASATINIB — Supplemental Application (Apotex Corp.)
The FDA approved Apotex Corp.'s supplemental application for dasatinib (DASATINIB).
-
FDA approval · 2025-08-28FDA Approved: DASATINIB — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for dasatinib (generic), enabling the continued availability of a generic DASATINIB thr…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia
This clinical trial update investigates CD81 expression in acute myeloid leukemia and chronic myeloid leukemia and explores its potential cl…
-
FDA approval · 2025-08-27FDA Approved: DASATINIB — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva Pharmaceuticals' original application to market a generic dasatinib product.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes [Phase 2]
Phase 2 trial update evaluating the infusion of expanded cord blood cells in addition to a single cord blood transplant for patients with ac…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: A Bioavailability Study of Nilotinib in Healthy, Adult, Human Subjects Under Fasted Conditions. [Phase 1]
A Phase 1 bioavailability study of nilotinib in healthy adult participants under fasted conditions has been completed.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Ropeginterferon for Treatment Free Remission [Phase 4]
Phase 4 trial evaluating Ropeginterferon alfa-2b for treatment-free remission in chronic myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell [Phase 1, Phase 2]
A completed Phase 1/2 study from Stanford evaluated a haploidentical hematopoietic cell transplantation approach using a T-cell depleted gra…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation [Phase 2]
This clinical trial update describes a Phase 2 study evaluating TCRγδ T cells and memory T cells with selective use of blinatumomab as part …
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia
A clinical trial is recruiting to investigate whether tyrosine kinase inhibitors used to treat Chronic Myeloid Leukemia are associated with …
-
FDA approval · 2025-08-01FDA Approved: PHYRAGO — Supplemental Application (Cycle Pharmaceuticals Ltd)
The FDA has approved a supplemental application for PHYRAGO (dasatinib) from Cycle Pharmaceuticals Ltd.
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation [Phase 2]
A Phase 2 trial evaluating treatment-free remission after asciminib-based therapy in chronic phase chronic myeloid leukemia patients who rel…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
A real-world patient registry study to describe experiences and clinical outcomes of chronic myeloid leukemia patients in the chronic phase …